Ig-like transcript 2 (ILT2) suppresses T cell function in chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

Ig-like transcript 2 (ILT2) suppresses T cell function in chronic lymphocytic leukemia

Published:2017-07-20 Issue:10 Volume:6 Page:e1353856
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Villa-Álvarez Mónica¹²³^ORCID,Lorenzo-Herrero Seila¹²³^ORCID,Gonzalez-Rodriguez Ana P.²⁴³,López-Soto Alejandro¹²³,Payer Angel R.⁴³,Gonzalez-Garcia Esther⁵³,Huergo-Zapico Leticia¹²,Gonzalez Segundo¹²³^ORCID

Affiliation:

1. Department of Functional Biology, University of Oviedo, Oviedo, Spain

2. IUOPA, University of Oviedo, Oviedo, Spain

3. Instituto de Investigación Sanitaria del Principado de Asturias (IISPA)

4. Department of Hematology, Hospital Universitario Central de Asturias (HUCA), Oviedo, Spain

5. Department of Hematology, Hospital Universitario de Cabueñes, Gijón, Spain

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2017.1353856

Reference50 articles.

1. From pathogenesis to treatment of chronic lymphocytic leukaemia

2. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

3. Prognostic significance of CD8 and CD4 T cells in chronic lymphocytic leukemia

4. Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia

5. Expansion of NK Cells and Reduction of NKG2D Expression in Chronic Lymphocytic Leukemia. Correlation with Progressive Disease

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cross‐talk between leukemic and immune cells at the tumor microenvironment in chronic lymphocytic leukemia: An update review;European Journal of Haematology;2024-05-02

2. Analysis of HLA-G 14 bp Insertion/Deletion Polymorphism and HLA-G, ILT2 and ILT4 Expression in Head and Neck Squamous Cell Carcinoma Patients;Diseases;2024-02-08

3. Immune response and treatment targets of chronic hepatitis B virus infection: innate and adaptive immunity;Frontiers in Cellular and Infection Microbiology;2023-06-22

4. Assessment of Impact of Human Leukocyte Antigen-Type and Cytokine-Type Responses on Outcomes after Targeted Therapy Currently Used to Treat Chronic Lymphocytic Leukemia;Journal of Clinical Medicine;2023-04-06

5. Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages;Frontiers in Immunology;2022-10-27